Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.22.1
Shareholders' Deficit (Tables)
 3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of activity related to non-vested shares
    Number of
Non-Vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2021     14,270,120     $ 0.14  
Granted    
-
      
-
  
Forfeited    
-
      
-
  
Shares vested    
-
      
-
  
Non-vested, March 31, 2022     14,270,120     $ 0.14  

 
Schedule of stock option activities
    Number of
Options		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding, December 31, 2021     8,445,698     $ 0.40       4.4     $           0  
Exercised    
-
      
-
      
-
      
-
  
Balance Outstanding, March 31, 2022     8,445,698     $ 0.40       4.2     $ 0  
Exercisable, March 31, 2022     8,445,698     $ 0.40       4.2     $ 0  

 
Schedule of warrant activities
    Number of
Warrants		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding December 31, 2021     17,500,000     $ 0.05       4.67     $
          -
  
Granted    
-
      
-
      
-
      
-
  
Exercised    
-
      
-
      
-
      
-
  
Balance Outstanding March 31, 2022     17,500,000     $ 0.05       4.42     $
-
  
Exercisable, March 31, 2022     17,500,000     $ 0.05       4.42     $
-